Institute of Biochemistry and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University Rehovot, Israel.
Front Endocrinol (Lausanne). 2012 Jul 10;3:79. doi: 10.3389/fendo.2012.00079. eCollection 2012.
Extracellular matrix mineralization is an essential physiologic process in bone, teeth, and hypertrophic cartilage. Matrix Gla protein (MGP), an inhibitor of mineralization, is expressed by chondrocytes and vascular smooth muscle cells to inhibit calcification of those soft tissues. Tibial dyschondroplasia (TD), a skeletal abnormality apparent as a plug of non-vascularized, non-mineralized, white opaque cartilage in the tibial growth plate of avian species can serve as a good model for studying process and genes involved in matrix mineralization and calcification. In this work, we studied the involvement of MGP in the development of TD, as well as in the processes of spontaneous and induced recovery from this syndrome. First, we found that during normal bone development, MGP is expressed in specific time and locations, starting from wide-spread expression in the yet un-ossified diaphysis during embryonic development, to specific expression in hypertrophic chondrocytes adjacent to the chondro-osseous junction and the secondary ossification center just prior to calcification. In addition, we show that MGP is not expressed in the impaired TD lesion, however when the lesion begins to heal, it strongly express MGP prior to its calcification. Moreover, we show that when calcification is inhibited, a gap is formed between the expression zones of MGP and BMP2 and that this gap is closed during the healing process. To conclude, we suggest that MGP, directly or through interaction with BMP2, plays a role as ossification regulator that acts prior to ossification, rather then simple inhibitor.
细胞外基质矿化是骨骼、牙齿和肥大软骨的基本生理过程。基质 Gla 蛋白(MGP)是一种矿化抑制剂,由软骨细胞和血管平滑肌细胞表达,以抑制这些软组织的钙化。胫骨软骨发育不良(TD)是一种骨骼异常,表现为禽类胫骨生长板中无血管、未矿化、白色不透明软骨的塞子,可作为研究基质矿化和钙化过程和基因的良好模型。在这项工作中,我们研究了 MGP 参与 TD 的发生,以及自发和诱导从这种综合征中恢复的过程。首先,我们发现,在正常骨骼发育过程中,MGP 在特定的时间和位置表达,从胚胎发育过程中未矿化骨干中的广泛表达开始,到临近软骨-骨交界处和二次骨化中心的肥大软骨细胞中的特异性表达,然后在钙化之前。此外,我们还表明,MGP 在受损的 TD 病变中不表达,但当病变开始愈合时,它在钙化之前强烈表达 MGP。此外,我们还表明,当钙化被抑制时,MGP 和 BMP2 的表达区域之间形成一个间隙,并且这个间隙在愈合过程中闭合。总之,我们认为 MGP 直接或通过与 BMP2 的相互作用,作为一种在骨化之前起作用的骨化调节剂,而不是简单的抑制剂。